A Diverse Leadership Team
We believe in healthier alternatives for horse medicine. Traditional equine pharmaceutical products are often overprescribed and can lead to negative side effects. Cannahorse provides horses and their owners with the scientifically-proven, plant-based medicine they’ve been searching for.
Founded by a team of equine professionals with unique experience in cannabis and animal pharmaceuticals, the safety and quality of CannaHorse products is of the utmost importance. As more jurisdictions allow veterinarians access to cannabis and hemp-derived health products, vets and horse owners are seeking quality, scientifically-proven products. Our products are formulated with medical-grade hemp, and are organic and vegan.
CannaHorse products are developed with the following principles in mind:
Research-driven product formulations
Research and development
Pharmaceutical grade ingredients
Reliable, consistent, and precise dosing
An experienced owner, breeder, and buyer of thoroughbred champions, whose marketing clients have included EquiLottery, the RCMP, and BBC Films.
Finance and Strategic Advisor
Former CitiBank Investment Banker and insurance executive, horse owner and amateur polo player.
Dr. Shea Porr, PhD
Head of Equine Science at Murray State University with world-leading equine cannabis knowledge.
Strainprint maintains the world's largest dataset on medical cannabis use in humans. Strainprint helps medical cannabis patients and doctors to use cannabis in the most effective and responsible way possible.
The data collected by Strainprint is used to guide doctors and patients to specific cannabis products, in order to treat specific ailments, based on cannabinoid and terpene formulas.
CannaHorse uses this data to determine the cannabinoid and terpene content and ratios for our product lines.
Biopharm is one of Europe's leading contract research organizations, based just outside Prague in the Czech Republic.
Biopharm received approval from the Czech Ministry of Health to conduct CannaHorse's initial pharmacokinetic, bioavailability and behavioural studies. These were among the first ever licenses by a federal government for invasive trials of cannabis on animals in Europe.
Bimeda is an Irish animal pharmaceutical manufacturer with manufacturing operations on 5 continents and sales to 75 countries. Based in Chicago, Bimeda manufacture leading equine products including Polyglycan and ConfidenceEQ among a number of anti-parasitic drugs, vaccines and others.
Bimeda aid CannaHorse in research, manufacturing and distribution strategy.